Expression of the p53 protein in oral squamous cell carcinomas associated with Epstein-Barr virus

Microbios

Volumn 102, Issue 403, 2000, Pages 147-154

  González Moles, Miguel Angel ^a   Galindo, Pablo ^a   Gutierrez, Jose ^a   Rodriguez Archilla, Alberto ^a   Ruiz Avila, Isabel ^b   Sanchez Fernandez, Elena ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Hospital General   (Spain)

Author keywords

Epstein Barr virus; Oral squamous cell carcinoma; p53 protein

Indexed keywords

PROTEIN P53;

ARTICLE; EPSTEIN BARR VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUTH TUMOR; SQUAMOUS CELL CARCINOMA; VIROLOGY; VIRUS INFECTION;

CARCINOMA, SQUAMOUS CELL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033643585     PISSN: 00262633     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. BASKIN G. B., Roberts E. D., Kuebler D., Martin L., Blauw B., Heeney J. and Zurcher C. 1995. Squamous epithelial proliferative lesions associated with rhesus Epstein-Barr virus in simian immunodeficiency virus-infected rhesus monkeys. J. infect. Dis. 172 535-9.
2. CORDON-CARDO C. 1995. Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia. Am. J. Path. 147 545-60.
3. EFFERT P., McCoy R., Abdel-Hamid M., Flynn K., Zhang Q., Busson P., Tursz T., Liu E. and Raab-Traub N. 1992. Alterations of the p53 gene in nasopharyngeal carcinoma. J. Virol. 66 3768-75.
4. FIELD J. K. 1992. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur. J. Cancer B. Oral. Oncol. 28B 67-76.
5. FRANK J. L., Bur M. E., Garb J. L., Kay S., Ware J., Sismanis A. and Neifeld J. P. 1994. P53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer 73 181-6.
6. GONZÁLEZ-MOLES M. A., Gutierrez J., Ruiz I., Fernandez J. A., Rodriguez M. and Aneiros J. 1998. Epstein-Barr virus and oral squamous cell carcinoma in patients without HIV infection: viral detection by polymerase chain reaction. Microbios 96 23-31.
7. GULLEY M. L., Pulitzer D. R., Eagan P. A. and Schneider B. G. 1996. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum. Pathol. 27 20-7.
8. GULLEY M. L., Burton M. P., Allred D. C., Nicholls J. M., Amin M. B., Ro J. Y. and Schneider B. G. 1998. Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma. Hum. Pathol. 29 252-9.
9. HOLLSTEIN M., Sidransky D., Vogelstein B. and Harris C. C. 1991. The p53 mutations in human cancers. Science 253 49-53.
10. LANE D. P. 1992. Cancer: p53, guardian of the genome. Nature 358 15-6.
11. LEUNG S. Y., Chau K. Y., Yuen S. T., Chu K. M., Branicki F. J. and Chung L. P. 1998. P53 overexpression is different in Epstein-Barr virus-associated and Epstein-Barr virus-negative carcinoma. Histopathology 33 311-7.
12. LO K. W., Mok C. H., Huang D. P., Liu Y. X., Choi P. H., Lee J. C. and Tsao S. W. 1992. P53 mutation in human nasopharyngeal carcinomas. Anticancer Res. 12 1957-63.
13. LUDLOW J. W. 1993. Interactions between SV40 large tumour antigen and the growth suppressor proteins pRB and p53. FASEB J. 7 866-71.
14. MARTEL-RENOIR D., Grunewald V., Touitou R., Schwaab G. and Joab I. 1995. Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinomas biopsies. J. gen. Virol. 76 1041-8.
15. MORAN E. 1993. Interactions of adenoviral proteins with pRB and p53. FASEB J. 7 880-5.
16. NAGAO T., Ishida Y., Sugano I., Tajima Y., Matsuzaki O., Hino T., Konno A., Kondo Y. and Nagao K. 1996. Epstein-Barr virus-associated undifferentiated carcinoma with lymphoid stroma of the salivary gland in Japanese patients. Comparison with benign lymphoepithelial lesion. Cancer 78 695-703.
17. NASRIN N., Taiba K., Hannan N., Hannan M. and al-Sedairy S. 1994. A molecular study of EBV DNA and p53 mutations in nasopharyngeal carcinoma of Saudi Arab patients. Cancer Letters 82 189-98.
18. NIEDOBITEK G., Agathanggelou A., Barber P., Smallman L. A., Yones E. L. and Young L. S. 1993. p53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J. Pathol. 170 457-61.
19. NIGRO J. M., Baker S. J., Preisinger A. C., Jessup J. M., Hostetter R. and Cleary K. 1989. Mutations in the p53 occur in diverse human tumour types. Nature 342 705-8.
20. NORUSIS N. 1993. SPSS for Windows. Release 6.0. SPSS Inc. Chicago, U.S.A.
21. SHEU L. F., Chen A., Tseng H. H., Leu F. J., Lin J. K. and Meng C. L. 1994. Expression of p53 protein in nasopharyngeal carcinoma. J. Pathol. 172 294-6.
22. SHEU L. F., Chen A., Tseng H. H., Leu F. J., Lin J. K., Ho K. C. and Meng C. L. 1995. Assessment of p53 expression in nasopharyngeal carcinoma. Hum. Pathol. 26 380-6.
23. SPRUCK C. H., Tsai Y. C., Huang D. P., Yang A. S., Rideout W. M., Gonzalez-Zulueta M., Choi P., Lo K. W., Yu M. C. and Jones P. A. 1992. Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Cancer Res. 52 4787-90.
24. SUN Y., Hegamyer G., Cheng Y. J., Hildesheim A., Chen J. Y., Chen I. H., Cao Y., Yao K. T. and Colburn N. H. 1992. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc. natn. Acad. Sci. U.S.A. 89 6516-20.
25. SZEKELY L., Selivanova G., Magnusson K. P., Klein G. and Wiman K. G. 1993. EBNA5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. natn. Acad. Sci. U.S.A. 90 5455-9.
26. VOUSDEN K. 1993. Interactions of human papillomavirus transforming proteins with the products of tumour suppressor genes. FASEB J. 7 872-9.
27. YIP T. T., Ngan R. K., Lau W. H., Poon Y. F., Joab I., Cochet C. and Cheng A. K. 1994. A possible prognostic role of immunoglobulin G antibody against recombinant Epstein-Barr virus BZLF1 transactivator protein ZEBRA in patients with nasopharyngeal carcinoma. Cancer 74 2414-24.
28. ZHANG Q., Gutsch D. and Kenney S. 1994. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Molec. cell. Biol. 14 1929-38.